Manina Medtech
Seedchrony, by Manina Medtech, provides a non-invasive diagnostic platform that assesses uterine readiness for embryo transfer in real time. By reading biomarker data directly from the uterus without a biopsy, the technology preserves endometrial integrity while delivering immediate results to clinicians. The platform aims to increase pregnancy rates by 30% by enabling more informed and individualized embryo transfer decisions.
- Healthcare Technology
- Digital Health
- Medical Devices
- Biotechnology
- Data & Analytics
- Hardware
- Software Only
- Artificial Intelligence
Funding
Founders
Founder details are not available yet.
Product
Problem
Embryo transfer success rates remain below 40%, and a key factor limiting success is the status of the maternal endometrium during implantation. Current methods for assessing endometrial receptivity often require invasive biopsies, which can compromise the endometrial lining and delay treatment, leaving clinicians without timely or accurate information to guide transfer decisions.
Solution
Seedchrony provides a non-invasive diagnostic platform that assesses uterine readiness for embryo transfer in real time. By reading biomarker data directly from the uterus without the need for a biopsy, the technology preserves endometrial integrity while delivering immediate and accurate results. This allows clinicians to make better-informed decisions about endometrial receptivity, enabling more effective and individualized embryo transfers. The platform is designed to increase pregnancy rates by 30% by supporting clinicians with real-time data on the optimal timing and condition for transfer.
Target Audience
Primary customers are IVF specialists, reproductive endocrinologists, and assisted reproduction clinics seeking to improve embryo transfer outcomes and personalize treatment for patients with implantation challenges.
Features
- Non-invasive biomarker analysis that eliminates the need for endometrial biopsy
- Real-time results that provide immediate clinical decision support during embryo transfer workflows
- High accuracy in assessing uterine receptivity, enabling personalized transfer timing
- Preserves endometrial integrity, reducing risk and improving patient comfort
- Designed to increase pregnancy rates by up to 30% through improved receptivity assessment